Literature DB >> 7934908

Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme.

C Croux1, C Ronda, R López, J L García.   

Abstract

Bacterial autolysins are endogenous enzymes that specifically cleave covalent bonds in the cell wall. These enzymes show both substrate and bond specificities. The former is related to their interaction with the insoluble substrate whereas the latter determine their site of action. The bond specificity allows their classification as muramidases (lysozymes), glucosaminidases, amidases, and endopeptidases. To demonstrate that the autolysin (LYC muramidase) of Clostridium acetobutylicum ATCC824 presents a domainal organization, a chimeric gene (clc) containing the regions coding for the catalytic domain of the LYC muramidase and the choline-binding domain of the pneumococcal phage CPL1 muramidase has been constructed by in vitro recombination of the corresponding gene fragments. This chimeric construction codes for a choline-binding protein (CLC) that has been purified using affinity chromatography on DEAE-cellulose. Several biochemical tests demonstrate that this rearrangement of domains has generated an enzyme with a choline-dependent muramidase activity on pneumococcal cell walls. Since the parental LYC muramidase was choline-independent and unable to degrade pneumococcal cell walls, the formation of this active chimeric enzyme by exchanging protein domains between two enzymes that specifically hydrolyse cell walls of bacteria belonging to different genera shows that a switch on substrate specificity has been achieved. The chimeric CLC muramidase behaved as an autolytic enzyme when it was adsorbed onto a live autolysin-defective mutant of Streptococcus pneumoniae. The construction described here provides experimental support for the theory of modular evolution which assumes that novel proteins have evolved by the assembly of preexisting polypeptide units.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7934908     DOI: 10.1111/j.1365-2958.1993.tb01231.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  19 in total

1.  Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.

Authors:  Mathias Schmelcher; Anne M Powell; Stephen C Becker; Mary J Camp; David M Donovan
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

2.  LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae.

Authors:  David G Pritchard; Shengli Dong; Marion C Kirk; Robert T Cartee; John R Baker
Journal:  Appl Environ Microbiol       Date:  2007-09-28       Impact factor: 4.792

Review 3.  Recombinant bacteriophage lysins as antibacterials.

Authors:  Mark Fenton; Paul Ross; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

4.  X-ray crystal structure of the streptococcal specific phage lysin PlyC.

Authors:  Sheena McGowan; Ashley M Buckle; Michael S Mitchell; James T Hoopes; D Travis Gallagher; Ryan D Heselpoth; Yang Shen; Cyril F Reboul; Ruby H P Law; Vincent A Fischetti; James C Whisstock; Daniel C Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-17       Impact factor: 11.205

5.  Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'.

Authors:  Mathias Schmelcher; Olga Korobova; Nina Schischkova; Natalia Kiseleva; Paul Kopylov; Sergey Pryamchuk; David M Donovan; Igor Abaev
Journal:  J Biotechnol       Date:  2012-09-28       Impact factor: 3.307

6.  Computationally Aided Discovery of LysEFm5 Variants with Improved Catalytic Activity and Stability.

Authors:  Tsvetelina H Baryakova; Seth C Ritter; Daniel T Tresnak; Benjamin J Hackel
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

Review 7.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

8.  Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Authors:  Anu Daniel; Chad Euler; Mattias Collin; Peter Chahales; Kenneth J Gorelick; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Structural basis of cell wall cleavage by a staphylococcal autolysin.

Authors:  Sebastian Zoll; Bernhard Pätzold; Martin Schlag; Friedrich Götz; Hubert Kalbacher; Thilo Stehle
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

10.  Genetic and biochemical characterization of the Lactobacillus delbrueckii subsp. lactis bacteriophage LL-H lysin.

Authors:  A Vasala; M Välkkilä; J Caldentey; T Alatossava
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.